170 related articles for article (PubMed ID: 3063285)
1. Comparative effects of captopril and nifedipine on split renal function in renovascular hypertension.
Miyamori I; Yasuhara S; Matsubara T; Takasaki H; Takeda R
Am J Hypertens; 1988 Oct; 1(4 Pt 1):359-63. PubMed ID: 3063285
[TBL] [Abstract][Full Text] [Related]
2. Contrasting acute effects of captopril and nifedipine on renal function in renovascular hypertension.
Ribstein J; Mourad G; Mimran A
Am J Hypertens; 1988 Jul; 1(3 Pt 1):239-44. PubMed ID: 3291894
[TBL] [Abstract][Full Text] [Related]
3. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril.
Textor SC; Tarazi RC; Novick AC; Bravo EL; Fouad FM
Am J Med; 1984 May; 76(5B):29-37. PubMed ID: 6328984
[TBL] [Abstract][Full Text] [Related]
4. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril.
Hollenberg NK
Am J Med; 1984 May; 76(5B):22-8. PubMed ID: 6328983
[TBL] [Abstract][Full Text] [Related]
5. Effect of nifedipine and captopril on glomerular hyperfiltration in normotensive man.
Böhler J; Woitas R; Keller E; Reetze-Bonorden P; Schollmeyer PJ
Am J Kidney Dis; 1992 Aug; 20(2):132-9. PubMed ID: 1496965
[TBL] [Abstract][Full Text] [Related]
6. Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition.
Reams GP; Singh A; Logan KW; Holmes RA; Bauer JH
J Clin Hypertens; 1987 Jun; 3(2):153-63. PubMed ID: 3039075
[TBL] [Abstract][Full Text] [Related]
7. Effects of converting enzyme inhibition on split renal function in renovascular hypertension.
Miyamori I; Yasuhara S; Takeda Y; Koshida H; Ikeda M; Nagai K; Okamoto H; Morise T; Takeda R; Aburano T
Hypertension; 1986 May; 8(5):415-21. PubMed ID: 3009326
[TBL] [Abstract][Full Text] [Related]
8. Effect of antihypertensive drugs on glomerular hyperfiltration and renal haemodynamics. Comparison of captopril with nifedipine, metoprolol and celiprolol.
Böhler J; Becker A; Reetze-Bonorden P; Woitas R; Keller E; Schollmeyer P
Eur J Clin Pharmacol; 1993; 44 Suppl 1():S57-61. PubMed ID: 8486148
[TBL] [Abstract][Full Text] [Related]
9. The captopril glomerular filtration rate renogram in renovascular hypertension.
Wilcox CS; Smith TB; Frederickson ED; Wingo CD; Phillips MI; Williams CM
Clin Nucl Med; 1989 Jan; 14(1):1-7. PubMed ID: 2653686
[TBL] [Abstract][Full Text] [Related]
10. Abnormal glomerular and tubular function during angiotensin converting enzyme inhibition in renovascular hypertension evaluated by the lithium clearance method.
Pedersen EB; Sørensen SS; Amdisen A; Danielsen H; Eiskjaer H; Hansen HH; Jensen FT; Jespersen B; Madsen B; Nielsen HK
Eur J Clin Invest; 1989 Apr; 19(2):135-41. PubMed ID: 2499471
[TBL] [Abstract][Full Text] [Related]
11. Effect of alpha-adrenergic blockers, ACE inhibitors, and calcium channel antagonists on renal function in hypertensive non-insulin-dependent diabetic patients.
Giordano M; Sanders LR; Castellino P; Canessa ML; DeFronzo RA
Nephron; 1996; 72(3):447-53. PubMed ID: 8852495
[TBL] [Abstract][Full Text] [Related]
12. Contrasting effects of acute angiotensin converting enzyme inhibitors and calcium antagonists in transplant renal artery stenosis.
Mourad G; Ribstein J; Argiles A; Mimran A; Mion C
Nephrol Dial Transplant; 1989; 4(1):66-70. PubMed ID: 2494601
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of deterioration in renal function in patients with renovascular hypertension treated with enalapril.
Bender W; La France N; Walker WG
Hypertension; 1984; 6(2 Pt 2):I193-7. PubMed ID: 6327522
[TBL] [Abstract][Full Text] [Related]
14. Filtration fraction.noninvasive measurement with Tc-99m DTPA and changes induced by angiotensin-converting enzyme inhibition in hypertension.
Peters AM; George P; Brown J; Lavender JP
Nephron; 1989; 51(4):470-3. PubMed ID: 2500611
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of converting enzyme inhibitors on split renal function in renovascular hypertension.
Miyamori I; Yasuhara S; Takeda R
Clin Exp Hypertens A; 1987; 9(2-3):629-32. PubMed ID: 3038426
[TBL] [Abstract][Full Text] [Related]
16. Glomerular hypertension in renovascular hypertensive patients.
Kimura G; London GM; Safar ME; Kuramochi M; Omae T
Kidney Int; 1991 May; 39(5):966-72. PubMed ID: 2067213
[TBL] [Abstract][Full Text] [Related]
17. Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals.
Takeyama K; Minato H; Nakatsuji K; Suzuki H; Nose I; Oka M; Hosoki K; Hatano N; Kadokawa T
Arzneimittelforschung; 1986; 36(1):69-73. PubMed ID: 3513779
[TBL] [Abstract][Full Text] [Related]
18. Renal functional response to captopril during diuretic therapy.
Lee HB; Blaufox MD
J Nucl Med; 1992 May; 33(5):739-43. PubMed ID: 1569484
[TBL] [Abstract][Full Text] [Related]
19. Renal response to pentobarbital anesthesia in rats: effect of interrupting the renin-angiotensin system.
Walker LA; Gellai M; Valtin H
J Pharmacol Exp Ther; 1986 Mar; 236(3):721-8. PubMed ID: 3512818
[TBL] [Abstract][Full Text] [Related]
20. Renal effects of nifedipine and captopril in patients with essential hypertension and reduced renal reserve.
Buzio C; Regolisti G; Perazzoli F; Mutti A; Bergamaschi E; Borghetti A
Hypertension; 1994 Dec; 24(6):763-9. PubMed ID: 7995635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
